ZNTL
Zentalis Pharmaceuticals, Inc.
Price Chart
No historical data available
Latest Quote
$3.80
-0.08 (-2.06%)
Current Price
| Previous Close | $3.88 |
| Open | $3.88 |
| Day High | $3.89 |
| Day Low | $3.72 |
| Volume | 695,394 |
Stock Information
| Shares Outstanding | 94.67M |
| Total Debt | $37.69M |
| Cash Equivalents | $174.61M |
| Net Income | $-139.54M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $359.75M |
| EPS (TTM) | $-1.92 |
| Exchange | NGM |
Recent Price History
No history data available. Data will be fetched automatically.
About Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. The company also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is based in San Diego, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on ZNTL.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $67,425,000 | $0 | $0 |
| Operating Revenue | $0 | $67,425,000 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $145,012,000 | $254,883,000 | $253,941,000 | $227,287,000 |
| Other Income Expense | $8,394,000 | $21,768,000 | $-22,951,000 | $5,987,000 |
| Operating Expense | $145,012,000 | $254,883,000 | $253,941,000 | $227,287,000 |
| General And Administrative Expense | $37,717,000 | $87,115,000 | $64,351,000 | $54,553,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-137,060,000 | $-165,839,000 | $-292,191,000 | $-236,806,000 |
| Normalized Income | $-143,691,260 | $-183,035,720 | $-269,285,902 | $-242,781,026 |
| Net Income From Continuing And Discontinued Operation | $-137,060,000 | $-165,839,000 | $-292,191,000 | $-236,806,000 |
| Total Operating Income As Reported | $-152,808,000 | $-191,194,000 | $-299,509,000 | $-227,287,000 |
| Net Income Common Stockholders | $-137,060,000 | $-165,839,000 | $-292,191,000 | $-236,806,000 |
| Net Income | $-137,060,000 | $-165,839,000 | $-292,191,000 | $-236,806,000 |
| Net Income Including Noncontrolling Interests | $-137,060,000 | $-165,867,000 | $-292,305,000 | $-237,113,000 |
| Net Income Continuous Operations | $-137,060,000 | $-165,867,000 | $-292,305,000 | $-237,113,000 |
| Earnings From Equity Interest Net Of Tax | $0 | $0 | $-16,014,000 | $-16,282,000 |
| Pretax Income | $-136,618,000 | $-165,690,000 | $-276,892,000 | $-221,300,000 |
| Special Income Charges | $-7,796,000 | $-3,736,000 | $-45,568,000 | $0 |
| Operating Income | $-145,012,000 | $-187,458,000 | $-253,941,000 | $-227,287,000 |
| Per Share | ||||
| Diluted EPS | $-1.91 | $-2.33 | $-4.47 | $-4.48 |
| Basic EPS | $-1.91 | $-2.33 | $-4.47 | $-4.48 |
| Other | ||||
| Tax Effect Of Unusual Items | $1,762,740 | $4,571,280 | $-45,902 | $11,974 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-152,667,000 | $-207,937,000 | $-229,601,000 | $-231,848,000 |
| Total Unusual Items | $8,394,000 | $21,768,000 | $-22,951,000 | $5,987,000 |
| Total Unusual Items Excluding Goodwill | $8,394,000 | $21,768,000 | $-22,951,000 | $5,987,000 |
| Reconciled Depreciation | $739,000 | $1,289,000 | $1,389,000 | $1,426,000 |
| EBITDA (Bullshit earnings) | $-144,273,000 | $-186,169,000 | $-252,552,000 | $-225,861,000 |
| EBIT | $-145,012,000 | $-187,458,000 | $-253,941,000 | $-227,287,000 |
| Diluted Average Shares | $71,869,000 | $71,080,000 | $65,409,000 | $52,857,000 |
| Basic Average Shares | $71,869,000 | $71,080,000 | $65,409,000 | $52,857,000 |
| Diluted NI Availto Com Stockholders | $-137,060,000 | $-165,839,000 | $-292,191,000 | $-236,806,000 |
| Minority Interests | $0 | $28,000 | $114,000 | $307,000 |
| Tax Provision | $442,000 | $177,000 | $-601,000 | $-469,000 |
| Impairment Of Capital Assets | $0 | $3,736,000 | $0 | $0 |
| Restructuring And Mergern Acquisition | $7,796,000 | $0 | $0 | - |
| Gain On Sale Of Security | $16,190,000 | $25,504,000 | $22,617,000 | $5,987,000 |
| Research And Development | $107,295,000 | $167,768,000 | $189,590,000 | $172,734,000 |
| Selling General And Administration | $37,717,000 | $87,115,000 | $64,351,000 | $54,553,000 |
| Other Gand A | $37,717,000 | $87,115,000 | $64,351,000 | $54,553,000 |
| Gain On Sale Of Business | - | - | $0 | $0 |
| Other Special Charges | - | - | $45,568,000 | - |
Fetched: 2026-08-29
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $216,204,000 | $337,186,000 | $433,548,000 | $430,067,000 |
| Total Assets | $288,967,000 | $430,337,000 | $551,688,000 | $539,310,000 |
| Total Non Current Assets | $35,776,000 | $44,271,000 | $54,970,000 | $87,377,000 |
| Other Non Current Assets | $6,735,000 | $7,044,000 | $9,499,000 | $12,350,000 |
| Current Assets | $253,191,000 | $386,066,000 | $496,718,000 | $451,933,000 |
| Other Current Assets | $7,298,000 | $9,982,000 | $13,799,000 | $14,562,000 |
| Receivables | $0 | $5,000,000 | $0 | $7,041,000 |
| Cash Cash Equivalents And Short Term Investments | $245,893,000 | $371,084,000 | $482,919,000 | $437,371,000 |
| Cash And Cash Equivalents | $35,995,000 | $33,901,000 | $28,038,000 | $43,069,000 |
| Goodwill And Other Intangible Assets | - | $0 | $3,736,000 | $3,736,000 |
| Other Receivables | - | $5,000,000 | - | $6,533,000 |
| Non Current Prepaid Assets | - | - | - | $9,723,000 |
| Restricted Cash | - | - | - | $0 |
| Prepaid Assets | - | - | - | $14,562,000 |
| Accrued Interest Receivable | - | - | - | $508,000 |
| Accounts Receivable | - | - | - | - |
| Debt | ||||
| Total Debt | $35,704,000 | $39,577,000 | $43,150,000 | $45,166,000 |
| Long Term Debt And Capital Lease Obligation | $35,704,000 | $39,577,000 | $43,150,000 | $45,166,000 |
| Current Debt And Capital Lease Obligation | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $72,763,000 | $93,151,000 | $114,297,000 | $105,286,000 |
| Total Non Current Liabilities Net Minority Interest | $36,204,000 | $40,426,000 | $44,930,000 | $48,639,000 |
| Other Non Current Liabilities | $500,000 | $849,000 | $1,780,000 | $2,620,000 |
| Current Liabilities | $36,559,000 | $52,725,000 | $69,367,000 | $56,647,000 |
| Payables And Accrued Expenses | $36,559,000 | $52,725,000 | $69,367,000 | $56,647,000 |
| Payables | $7,208,000 | $7,438,000 | $14,926,000 | $11,247,000 |
| Accounts Payable | $7,208,000 | $7,438,000 | $14,926,000 | $11,247,000 |
| Non Current Deferred Liabilities | - | - | $0 | $853,000 |
| Non Current Deferred Taxes Liabilities | - | - | $0 | $853,000 |
| Total Tax Payable | - | - | - | - |
| Income Tax Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $216,204,000 | $337,186,000 | $437,284,000 | $433,803,000 |
| Total Equity Gross Minority Interest | $216,204,000 | $337,186,000 | $437,391,000 | $434,024,000 |
| Stockholders Equity | $216,204,000 | $337,186,000 | $437,284,000 | $433,803,000 |
| Gains Losses Not Affecting Retained Earnings | $196,000 | $558,000 | $2,194,000 | $-1,353,000 |
| Other Equity Adjustments | $196,000 | $558,000 | $2,194,000 | $-1,353,000 |
| Retained Earnings | $-1,191,455,000 | $-1,054,395,000 | $-888,556,000 | $-596,365,000 |
| Long Term Equity Investment | - | - | $0 | $21,213,000 |
| Other | ||||
| Ordinary Shares Number | $69,085,980 | $71,282,400 | $70,765,554 | $59,280,247 |
| Share Issued | $69,085,980 | $71,282,400 | $70,765,554 | $59,280,247 |
| Tangible Book Value | $216,204,000 | $337,186,000 | $433,548,000 | $430,067,000 |
| Invested Capital | $216,204,000 | $337,186,000 | $437,284,000 | $433,803,000 |
| Working Capital | $216,632,000 | $333,341,000 | $427,351,000 | $395,286,000 |
| Capital Lease Obligations | $35,704,000 | $39,577,000 | $43,150,000 | $45,166,000 |
| Total Capitalization | $216,204,000 | $337,186,000 | $437,284,000 | $433,803,000 |
| Additional Paid In Capital | $1,407,394,000 | $1,390,952,000 | $1,323,576,000 | $1,031,462,000 |
| Capital Stock | $69,000 | $71,000 | $70,000 | $59,000 |
| Common Stock | $69,000 | $71,000 | $70,000 | $59,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $35,704,000 | $39,577,000 | $43,150,000 | $45,166,000 |
| Current Accrued Expenses | $29,351,000 | $45,287,000 | $54,441,000 | $45,400,000 |
| Net PPE | $29,041,000 | $37,227,000 | $41,735,000 | $50,078,000 |
| Accumulated Depreciation | $-2,774,000 | $-4,274,000 | $-3,148,000 | $-2,060,000 |
| Gross PPE | $31,815,000 | $41,501,000 | $44,883,000 | $52,138,000 |
| Leases | $4,168,000 | $4,168,000 | $4,235,000 | $4,891,000 |
| Other Properties | $26,271,000 | $35,910,000 | $38,985,000 | $44,995,000 |
| Machinery Furniture Equipment | $1,376,000 | $1,423,000 | $1,490,000 | $2,215,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $209,898,000 | $337,183,000 | $454,881,000 | $394,302,000 |
| Minority Interest | - | $0 | $107,000 | $221,000 |
| Goodwill | - | $0 | $3,736,000 | $3,736,000 |
| Construction In Progress | - | $0 | $173,000 | $37,000 |
| Investments And Advances | - | - | $0 | $21,213,000 |
| Investmentsin Associatesat Cost | - | - | $0 | $21,213,000 |
| Investmentsin Joint Venturesat Cost | - | - | - | $21,213,000 |
| Current Capital Lease Obligation | - | - | - | - |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | - | - |
Fetched: 2026-08-29
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-125,247,000 | $-171,081,000 | $-208,405,000 | $-166,299,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-125,247,000 | $-170,860,000 | $-207,822,000 | $-163,751,000 |
| Cash Flow From Continuing Operating Activities | $-125,247,000 | $-170,860,000 | $-207,822,000 | $-163,751,000 |
| Operating Gains Losses | $-660,000 | $-92,000 | $16,420,000 | $16,338,000 |
| Investing Activities | ||||
| Investing Cash Flow | $131,623,000 | $176,561,000 | $-44,458,000 | $-114,180,000 |
| Cash Flow From Continuing Investing Activities | $131,623,000 | $176,561,000 | $-44,458,000 | $-114,180,000 |
| Capital Expenditure | - | $-221,000 | $-583,000 | $-2,548,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-9,976,000 | $0 | $0 | - |
| Issuance Of Capital Stock | $5,694,000 | $349,000 | $237,303,000 | $261,043,000 |
| Financing Cash Flow | $-4,282,000 | $108,000 | $237,303,000 | $261,043,000 |
| Cash Flow From Continuing Financing Activities | $-4,282,000 | $108,000 | $237,303,000 | $261,043,000 |
| Net Common Stock Issuance | $-4,282,000 | $349,000 | $237,303,000 | $261,043,000 |
| Common Stock Issuance | $5,694,000 | $349,000 | $237,303,000 | $261,043,000 |
| Net Other Financing Charges | - | $-241,000 | - | - |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Income Tax Paid Supplemental Data | $85,000 | $359,000 | $140,000 | $12,000 |
| End Cash Position | $38,622,000 | $36,528,000 | $30,719,000 | $45,696,000 |
| Beginning Cash Position | $36,528,000 | $30,719,000 | $45,696,000 | $62,584,000 |
| Changes In Cash | $2,094,000 | $5,809,000 | $-14,977,000 | $-16,888,000 |
| Common Stock Payments | $-9,976,000 | $0 | $0 | - |
| Net Investment Purchase And Sale | $130,925,000 | $176,717,000 | $-43,875,000 | $-111,632,000 |
| Sale Of Investment | $270,413,000 | $304,679,000 | $505,307,000 | $421,529,000 |
| Purchase Of Investment | $-139,488,000 | $-127,962,000 | $-549,182,000 | $-533,161,000 |
| Net PPE Purchase And Sale | $698,000 | $-156,000 | $-583,000 | $-2,548,000 |
| Sale Of PPE | $698,000 | $65,000 | $0 | $0 |
| Purchase Of PPE | $0 | $-221,000 | $-583,000 | $-2,548,000 |
| Change In Working Capital | $-9,122,000 | $-16,540,000 | $5,864,000 | $13,252,000 |
| Change In Other Working Capital | $201,000 | $264,000 | $623,000 | $4,330,000 |
| Change In Payables And Accrued Expense | $-17,316,000 | $-18,022,000 | $10,919,000 | $15,527,000 |
| Change In Payable | $-17,316,000 | $-18,022,000 | $10,919,000 | $15,527,000 |
| Change In Account Payable | $-17,316,000 | $-18,022,000 | $10,919,000 | $15,527,000 |
| Change In Prepaid Assets | $2,993,000 | $6,218,000 | $-5,678,000 | $-6,605,000 |
| Change In Receivables | $5,000,000 | $-5,000,000 | $0 | $0 |
| Changes In Account Receivables | $5,000,000 | $-5,000,000 | $0 | $0 |
| Stock Based Compensation | $20,722,000 | $67,269,000 | $54,822,000 | $46,840,000 |
| Unrealized Gain Loss On Investment Securities | $-1,239,000 | $-5,228,000 | $0 | $0 |
| Asset Impairment Charge | $4,136,000 | $3,736,000 | $4,953,000 | $0 |
| Amortization Of Securities | $-2,763,000 | $-8,002,000 | $-13,157,000 | $-3,725,000 |
| Deferred Tax | $0 | $0 | $-853,000 | $-769,000 |
| Deferred Income Tax | $0 | $0 | $-853,000 | $-769,000 |
| Depreciation Amortization Depletion | $739,000 | $1,289,000 | $1,389,000 | $1,426,000 |
| Depreciation And Amortization | $739,000 | $1,289,000 | $1,389,000 | $1,426,000 |
| Earnings Losses From Equity Investments | $0 | $0 | $16,014,000 | $16,282,000 |
| Gain Loss On Sale Of PPE | $-660,000 | $-13,000 | $406,000 | $56,000 |
| Gain Loss On Sale Of Business | $0 | $-79,000 | $0 | $0 |
| Net Income From Continuing Operations | $-137,060,000 | $-165,867,000 | $-292,305,000 | $-237,113,000 |
| Other Non Cash Items | - | $-47,425,000 | $15,045,000 | - |
| Net Business Purchase And Sale | - | - | $0 | $0 |
| Purchase Of Business | - | - | $0 | $0 |
Fetched: 2026-08-29